Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06694714 · ClinicalTrials.gov registry record · Phase 4

Split Face Study of the Duration of Local Anesthetics - Fourth Arm

A Phase 4 study of Anesthesia, Local, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
Phase 4
Development phase
35
Enrollment target
1
Study location

NCT06694714 is a Phase 4 study of Anesthesia, Local that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 35 participants, below the 81-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06694714, a Phase 4 study of Anesthesia, Local, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
Phase 4
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

This is a research study to compare how long injectable pain medications (anesthetics) commonly used in dermatologic surgery are effective for. The investigators will investigate the role of anesthetic volume on the duration of action at highly vascular sites.

Conditions Studied

Interventions

  • DRUG 0.5 ml lidocaine + epinephrine 1:100,000
  • DRUG 1.0 ml lidocaine + epinephrine 1:100,000

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2025-01-21
Est. Completion 2027-06-01
Phase Phase 4

What the Registry Record Tells You About NCT06694714

The ClinicalTrials.gov registry entry for NCT06694714 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (57% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anesthesia, Local appearing as the primary indexed condition, and to 2 interventions - of which 0.5 ml lidocaine + epinephrine 1:100,000 is the first listed.

NCT06694714 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06694714 about?

NCT06694714 is a clinical study titled "Split Face Study of the Duration of Local Anesthetics - Fourth Arm". This is a research study to compare how long injectable pain medications (anesthetics) commonly used in dermatologic surgery are effective for. The investigators will investigate the role of anesthetic volume on the duration of action at highly vascular sites.

What is the current status of trial NCT06694714?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2025-01-21. Estimated completion is 2027-06-01.

What conditions does trial NCT06694714 study?

This clinical trial studies the following conditions: Anesthesia, Local.

What interventions are being tested in trial NCT06694714?

The interventions under investigation include: 0.5 ml lidocaine + epinephrine 1:100,000 (DRUG), 1.0 ml lidocaine + epinephrine 1:100,000 (DRUG).

Who is sponsoring clinical trial NCT06694714?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06694714 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia, Local

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.